Institution
Yale New Haven Hospital
Also known as: YNHH
- 206running trials
- 74closed trials
- 12,115publications (OpenAlex)
Running trials
Recruiting
Not yet recruiting
COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"
Not yet recruiting
Not yet recruiting
Recruiting
A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML
Recruiting
Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
Recruiting
A Study of the Safety and Efficacy of Prime Editing (PM577) in Participants With Wilson Disease (WD)
Recruiting
Not yet recruiting
Recruiting
A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma
Recruiting
Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation
Recruiting
Recruiting
Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome
Recruiting
Recruiting
Recruiting
Active, not recruiting
Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical Trial
Recruiting
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Recruiting
Recruiting
Recruiting
Recruiting
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Recruiting
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)
Recruiting
Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Recruiting
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
Recruiting
Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Recruiting
Active, not recruiting
Recruiting
Recruiting
Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition
Active, not recruiting
Showing 50 of 206.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Stroke10 recruiting
- Childhood cancers7 recruiting
- Colorectal cancer7 recruiting
- Lung cancer7 recruiting
- Metastatic breast cancer7 recruiting
- Prostate cancer7 recruiting
- Multiple myeloma5 recruiting
- Pancreatic cancer5 recruiting
- Head and neck cancer4 recruiting
- Acute myeloid leukaemia3 recruiting
- Bladder cancer3 recruiting
- Epilepsy3 recruiting
- Gastric and oesophageal cancer3 recruiting
- Heart failure3 recruiting
- Ovarian cancer3 recruiting
- Sarcoma3 recruiting
- Acute lymphoblastic leukaemia2 recruiting
- Coronary artery disease2 recruiting
- Dermatomyositis and polymyositis (myositis)2 recruiting
- Fatty liver disease (MASLD/MASH)2 recruiting
- High blood pressure2 recruiting
- Liver and biliary tract cancer2 recruiting
- Lupus (SLE)2 recruiting
- Myasthenia gravis2 recruiting
- Psoriasis2 recruiting
- Psoriatic arthritis2 recruiting
- Rheumatoid arthritis2 recruiting
- Sarcoidosis2 recruiting
- Sjögren's disease2 recruiting
- Systemic sclerosis (scleroderma)2 recruiting
- Triple-negative breast cancer2 recruiting
- Type 2 diabetes2 recruiting
- Ankylosing spondylitis1 recruiting
- Antiphospholipid syndrome1 recruiting
- Aortic aneurysm1 recruiting
- Aortic stenosis1 recruiting
- Aplastic anaemia1 recruiting
- Atrial fibrillation1 recruiting
- Brain aneurysm1 recruiting
- Brain metastases1 recruiting
- Burkitt lymphoma1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Chronic myeloid leukaemia1 recruiting
- COPD1 recruiting
- Crohn's disease1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Giant cell arteritis1 recruiting
- Hodgkin lymphoma1 recruiting
- Hypertrophic cardiomyopathy1 recruiting
- Immune thrombocytopenia (ITP)1 recruiting
- Kidney cancer1 recruiting
- Lyme disease1 recruiting
- Melanoma1 recruiting
- Meningioma1 recruiting
- Multiple sclerosis1 recruiting
- Neuroblastoma1 recruiting
- Neuroendocrine tumours1 recruiting
- Obesity1 recruiting
- Parkinson disease1 recruiting
- Peripheral artery disease1 recruiting
- Polymyalgia rheumatica1 recruiting
- Pulmonary arterial hypertension1 recruiting
- Sickle cell disease1 recruiting
- Thyroid cancer1 recruiting
- Type 1 diabetes1 recruiting
- Ulcerative colitis1 recruiting
- Wilson disease1 recruiting
Closed trials
Completed
Completed
Terminated
Completed
Adaptive Decision Support for Addiction Treatment (ADAPT) Factorial Trial
Recruiting
Recruiting
Withdrawn
Completed
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
Completed
Completed
Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility Study
Completed
Completed
Terminated
Completed
Completed
Terminated
Feasibility Study: tDCS for Treatment of Refractory Status Epilepticus
Completed
Terminated
Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC
Recruiting
Completed
Completed
Completed
Completed
Terminated
Withdrawn
Completed
Terminated
Terminated
Completed
Prescription Digital Therapeutic for the Treatment of Insomnia
Completed
Ketamine for the Treatment of Depression in Parkinson's Disease
Completed
Stimulation of the Thalamus for Arousal Restoral in Temporal Lobe Epilepsy
Completed
Withdrawn
Reversibility of Brain Glucose Transport and Metabolism in T2DM: an Intervention Study
Terminated
Completed
Completed
Completed
Completed
Metabolic Changes Induced by a Very Low Carbohydrate Diet in Youth With Type 1 Diabetes
Completed
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3
Completed
Completed
Completed
Terminated
Blood PREssure Augmentation in Large-vessel Occlusion Stroke Study
Completed
Completed
Completed
Emergency Department-Initiated Buprenorphine Validation Network Trial
Completed
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)
Completed
Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients
Completed
SCOPE CLI (Shifting Care and Outcomes for Patients With Endangered Limbs - Critical Limb Ischemia)
Completed
Showing 50 of 74.
Registry name variants (28)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Yale New Haven Hospital
New Haven, Connecticut 06510
139 trials
Smilow Cancer Center/Yale-New Haven Hospital
New Haven, Connecticut 06510
95 trials
Yale - New Haven Hospital - Yale Cancer Center
New Haven, Connecticut 06510
16 trials
Yale School of Medicine - Yale-New Haven Hospital
New Haven, Connecticut 06519
4 trials
Yale University - Yale New Haven Hospital
New Haven, Connecticut 06510
4 trials
Yale New Haven Hospital
New York, New York 10032
2 trials
Yale New Haven Hospital - York Street Campus
New Haven, Connecticut 06510
2 trials
Yale Cancer Center - Yale New Haven Hospital
New Haven, Connecticut 06520
1 trial
Contact: Principal Investigator
Yale New Haven Health (Yale New Haven Hospital)
New Haven, Connecticut 06510
1 trial
Yale New Haven Hosp
New Haven, Connecticut 06519
1 trial
NCT03072927MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Contact: Angie Lee
Yale New Haven Hospital
New Have, Connecticut 06510
1 trial
Yale-New Haven Hospital
North Haven, Connecticut 06473
1 trial
Yale - New Haven Hospital / Cancer Center
New Haven, Connecticut 06510
1 trial
NCT07751991A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML
Contact: Maximilian Stahl, MD
Yale New Haven Hospital (CICU or MICU)
New Haven, Connecticut 06520
1 trial
Yale New Haven Hospital
New Haven, Connecticut 06510
1 trial
Yale New Haven Hospital
New Haven, Connecticut 06510
1 trial
Yale New Haven Hospital
New Haven, Connecticut 06510
1 trial
Yale New Haven Hospital, Saint Raphael Campus (MRE location)
New Haven, Connecticut 06511
1 trial
Yale New Haven Hospital (Site 0001)
New Haven, Connecticut 06520
1 trial
Yale New Haven Hospital (Site 1012)
New Haven, Connecticut 06510
1 trial
Yale New Haven Hospital (Site 1093)
New Haven, Connecticut 06520
1 trial
Yale-New Haven Hospital (Site 2012)
New Haven, Connecticut 06510
1 trial
Yale New Haven Hospital (Site 3012)
New Haven, Connecticut 06510
1 trial
Contact: Study Coordinator
Yale New Haven Hospital- Site Number : 8400065
New Haven, Connecticut 06510
1 trial
Yale-New Haven Hospital - Yale Cancer Center
North Haven, Connecticut 06473 2195
1 trial
Yale New Haven Hospital, Yale School of Medicine
New Haven, Connecticut 06510
1 trial
Yale New Haven Hospital (YNHH) Research Unit (HRU)
New Haven, Connecticut 06520
1 trial
NCT05776563Reversibility of Brain Glucose Transport in Type 2 Diabetes Mellitus (T2DM)
Contact: Elizabeth Sanchez Rangel, MD
Yale University School of Medicine - Yale-New Haven Hospital
New Haven, Connecticut 06510
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Deep vein thrombosis and pulmonary embolism38 works · 2 trials
- Aortic aneurysm14 works · 1 trial
- Peripheral artery disease7 works · 5 trials
Institution data: ROR 05tszed37 (CC0-1.0)Updated 15 Nov 2026